Promoters of Max Healthcare Institute Limited have confirmed that no shares of the company were encumbered during the financial year 2025-26. Abhay Soi, a promoter, and Aditya Soi, a member of the promoter group, declared that they have not created any encumbrance on the shares of the company, either directly or indirectly, throughout the period. This disclosure ensures that the promoter group's shareholding remains free from charges or pledges, which is a key indicator of financial stability for investors.

The declaration was submitted to the National Stock Exchange of India Limited and BSE Limited on April 06, 2026. The filing was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation requires promoters to disclose any encumbrance on their holdings to ensure transparency in the shareholding structure of listed entities.

The disclosure was addressed to the Listing Departments of both exchanges and copied to the Chairman and the Audit Committee of Max Healthcare Institute Limited. The company's scrip code on the BSE is 543220, and it trades under the symbol MAXHEALTH.

Max Healthcare Institute Limited reported a 22% increase in Profit After Tax (PAT) to INR 1,631 crore for the financial year ended March 31, 2026, compared to INR 1,336 crore in the previous year. The Network delivered its 22nd consecutive quarter of year-on-year growth, with Q4 FY26 PAT reaching INR 387 crore. The company announced these results during its earnings conference call held on May 22, 2026.

Financial Performance

The Network gross revenue for FY26 stood at INR 10,538 crore, reflecting a 16% year-on-year growth. For the quarter ended March 31, 2026, gross revenue increased by 10% year-on-year to INR 2,664 crore. Operating EBITDA for the full year grew by 14% to INR 2,638 crore, with a margin of 26.2%. In Q4, operating EBITDA was INR 682 crore, an 8% year-on-year increase.

Operational Highlights

Average occupancy for the Network remained above 75% despite an increase in operational bed capacity. Occupied bed days (OBDs) grew by 8% year-on-year and 4% quarter-on-quarter. The Average Revenue Per Occupied Bed (ARPOB) for Q4 stood at INR 77,900. International patient revenue was INR 227 crore, accounting for 9% of hospital revenue, while digital revenue contributed INR 838 crore, or 31% of overall revenue.

Expansion and Acquisition Updates

The company completed the acquisition of a controlling stake in Kalinga Hospital Limited, marking its entry into Eastern India. The Board approved an investment of INR 1,400 crore for a new 700-bed greenfield hospital in Lucknow. Expansion projects include a 500-bed hospital in Sector 56 Gurgaon, targeted for commissioning by the end of the year, and capacity additions in Mohali, Nanavati, and Max Smart.

The disclosure was made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transcript of the earnings call is available on the company's website.